Physiological Suppression of Lipotoxic Liver Damage by Complementary Actions of HDAC3 and SCAP/SREBP
- 1 December 2016
- journal article
- Published by Elsevier in Cell Metabolism
- Vol. 24 (6) , 863-874
Abstract
No abstract availableKeywords
Funding Information
- NIH (R37 DK43806, F32 DK108555, R00 DK099443, F32 DK101175, T32 GM008216)
This publication has 52 references indexed in Scilit:
- Hepatic Hdac3 promotes gluconeogenesis by repressing lipid synthesis and sequestrationNature Medicine, 2012
- Nuclear Receptors Reverse McGarry's Vicious Cycle to Insulin ResistanceCell Metabolism, 2012
- The Scap/SREBP Pathway Is Essential for Developing Diabetic Fatty Liver and Carbohydrate-Induced Hypertriglyceridemia in AnimalsCell Metabolism, 2012
- Excessive Hepatic Mitochondrial TCA Cycle and Gluconeogenesis in Humans with Nonalcoholic Fatty Liver DiseaseCell Metabolism, 2011
- Postprandial Hepatic Lipid Metabolism Requires Signaling through Akt2 Independent of the Transcription Factors FoxA2, FoxO1, and SREBP1cCell Metabolism, 2011
- A Circadian Rhythm Orchestrated by Histone Deacetylase 3 Controls Hepatic Lipid MetabolismScience, 2011
- Akt2 Is Required for Hepatic Lipid Accumulation in Models of Insulin ResistanceCell Metabolism, 2009
- JNK1-dependent PUMA Expression Contributes to Hepatocyte LipoapoptosisJournal of Biological Chemistry, 2009
- Mitochondrial dysfunction due to long-chain Acyl-CoA dehydrogenase deficiency causes hepatic steatosis and hepatic insulin resistanceProceedings of the National Academy of Sciences, 2007
- Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genesProceedings of the National Academy of Sciences, 2003